semaglutide and tirzepatide for weight loss Semaglutide/Tirzepatide: Beyond Loss: Shamsah Amersi, MD: OB-GYNs I compare two weight loss

GLP-1 receptors have been identified in various tissues throughout the body, including the cardiovascular system, kidneys, and vascular endothelium

Moran Eye Center, Department of Ophthalmology & Visual Sciences, and Department of Neurology at the University of Utah Health, has identified ophthalmic complications in patients taking semaglutide and tirzepatide, two medications commonly prescribed for diabetes management

It is well known that GLP-1Rs themselves are inactive and needs to be activated or inhibited to exert their function

In clinical trials, tirzepatide has consistently produced greater average weight loss than semaglutide alone, which is why it is generating significant interest among patients and doctors in Thailand

Diabetes Obes Metab 20:13371341